蒲公英 - 制药技术的传播者 GMP理论的实践者

搜索
查看: 2709|回复: 3
收起左侧

[GMP相关] FDA警告信—ERP和校准

[复制链接]
药士
发表于 2016-10-2 21:47:43 | 显示全部楼层 |阅读模式

欢迎您注册蒲公英

您需要 登录 才可以下载或查看,没有帐号?立即注册

x
CSV FDA Warning Letters : ERP and Calibration


Date: 07 May 2009
Link: FDA Warning Letter (New Window)

Observation4. Failure to routinely calibrate, inspect, or check according to a written program designed to assure proper performance of automatic, mechanical, or electronic equipment, including computers, used in the manufacture, processing, packing and holding of a drug product. [21 CFR 211.68]

Part A
A. The Enterprise Resource Planning System known as the firm's Systems Applications and Products
(SAP) computer database allows rejected batches of drug product to be in Unrestricted Status (to be released for distribution). Refer to Form FDA 483, Observation #3.

Part B
B.
Failure to retain original calibration data for [(b)(4)] used in the re-qualification of the [(b)(4)].(原始的校验数据缺失) Refer to Form FDA 483, Observation #4b.

CommentBoth parts of this observation could have been allocated to the ruling for Electronic Records, Electronic Signatures 21 CFR Part 11, however the agency chose not to cite against this rule, favouring 21 CFR 211.

This is a trend that has been observed when reviewing warning letters.

Part A for the SAP Enterprise Resource Planning (ERP) System relates to the security of the data and the ability for transactions to be made by unauthorised personnel on rejected batches. This is a serious product quality issue as it is possible for a Rejected Batch to be released for use.

The key to avoiding this pit fall is to ensure that documented risk assessments are performed.
For an ERP system a number of assessments may need to be performed against various functional aspects. Also the security privileges should have been assessed and the access list should have also covered what roles have access to each function(ERP各模块和功能的权限设置).

Verification through testing should be performed to ensure that the configured user settings provide the required controls and that a Standard Operating Procedure (SOP) is developed for the control and maintenance of user access.(用户权限设置后的测试确认记录)

Part B relates to calibration records, and the retaining of raw data. This is an interesting observation as many companies transcribe the raw data (calibration results) to a calibration management system and then discard the paper copies.(校验原始记录的誊抄行为) When taking this approach it is important to have a Standard Operating Procedure (SOP) in place which will document what is the primary calibration record, how the record will be verified (within a calibration database) and the role of the quality organisation.


Posted by Barry Tedstone    No comments:   

Labels: FDA Warning Letters


回复

使用道具 举报

药生
发表于 2016-10-4 20:10:15 | 显示全部楼层
回复

使用道具 举报

药徒
发表于 2016-11-18 09:23:27 | 显示全部楼层

谢谢分享,学习了
回复

使用道具 举报

药徒
发表于 2016-11-22 20:16:16 | 显示全部楼层
回复

使用道具 举报

药徒
发表于 2017-10-13 20:00:22 | 显示全部楼层
学习了,ERP现在确实比较头痛
回复

使用道具 举报

您需要登录后才可以回帖 登录 | 立即注册

本版积分规则

×发帖声明
1、本站为技术交流论坛,发帖的内容具有互动属性。您在本站发布的内容:
①在无人回复的情况下,可以通过自助删帖功能随时删除(自助删帖功能关闭期间,可以联系管理员微信:8542508 处理。)
②在有人回复和讨论的情况下,主题帖和回复内容已构成一个不可分割的整体,您将不能直接删除该帖。
2、禁止发布任何涉政、涉黄赌毒及其他违反国家相关法律、法规、及本站版规的内容,详情请参阅《蒲公英论坛总版规》。
3、您在本站发表、转载的任何作品仅代表您个人观点,不代表本站观点。不要盗用有版权要求的作品,转贴请注明来源,否则文责自负。
4、请认真阅读上述条款,您发帖即代表接受上述条款。

QQ|手机版|蒲公英|ouryao|蒲公英 ( 京ICP备14042168号-1 )  京ICP证150354号  互联网药品信息服务证书编号: (京)-非经营性-2024-0033

GMT+8, 2024-11-13 16:01

Powered by Discuz! X3.4运维单位:苏州豚鼠科技有限公司

Copyright © 2001-2020, Tencent Cloud.

声明:蒲公英网站所涉及的原创文章、文字内容、视频图片及首发资料,版权归作者及蒲公英网站所有,转载要在显著位置标明来源“蒲公英”;禁止任何形式的商业用途。违反上述声明的,本站及作者将追究法律责任。
快速回复 返回顶部 返回列表